Skip to main content

Advertisement

SpringerLink
Log in

The multifaceted role of reactive oxygen species in tumorigenesis

  • Review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract

Redox homeostasis is an essential requirement of the biological systems for performing various normal cellular functions including cellular growth, differentiation, senescence, survival and aging in humans. The changes in the basal levels of reactive oxygen species (ROS) are detrimental to cells and often lead to several disease conditions including cardiovascular, neurological, diabetes and cancer. During the last two decades, substantial research has been done which clearly suggests that ROS are essential for the initiation, progression, angiogenesis as well as metastasis of cancer in several ways. During the last two decades, the potential of dysregulated ROS to enhance tumor formation through the activation of various oncogenic signaling pathways, DNA mutations, immune escape, tumor microenvironment, metastasis, angiogenesis and extension of telomere has been discovered. At present, surgery followed by chemotherapy and/or radiotherapy is the major therapeutic modality for treating patients with either early or advanced stages of cancer. However, the majority of patients relapse or did not respond to initial treatment. One of the reasons for recurrence/relapse is the altered levels of ROS in tumor cells as well as in cancer-initiating stem cells. One of the critical issues is targeting the intracellular/extracellular ROS for significant antitumor response and relapse-free survival. Indeed, a large number of FDA-approved anticancer drugs are efficient to eliminate cancer cells and drug resistance by increasing ROS production. Thus, the modulation of oxidative stress response might represent a potential approach to eradicate cancer in combination with FDA-approved chemotherapies, radiotherapies as well as immunotherapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

Abbreviations

5-FU:

5-Fluorouracil

ABC:

ATP-binding cassette

AML:

Adult acute myeloid leukemia

AMPK 5′:

AMP-activated protein kinase

APAF1:

Apoptosis protease-activating factor 1

ATP:

Adenosine triphosphate

ART:

Artesunate

ASK-1:

Apoptosis signal-regulated kinase 1

BSO:

Buthionine sulfoximine

BCL-2:

B cell lymphoma 2

CAR:

Chimeric antigen receptor

CAT:

Catalase

CSCs:

Cancer stem cells

EGFR:

Epidermal growth factor receptor

EGF:

Epidermal growth factor

ER:

Endoplasmic reticulum

ERK:

Extracellular regulated kinase

ETC:

Electron transport chain

EMT:

Epithelial–mesenchymal transition

eNOS:

Endothelial nitric oxide synthase

GPX:

Glutathione peroxidase

GSH:

Glutathione

GCL:

Glutamate-cysteine ligase

GSS:

GSH synthetase

GSSG:

GSH disulfide

GPX4:

Glutathione peroxidase 4

H2O2 :

Hydrogen peroxide

HCC:

Hepatocellular carcinoma

HER2:

Human epidermal growth factor receptor 2

HGF:

Hepatocyte growth factor

HIF-1:

Hypoxia-inducible factor

hTERT:

Human telomerase reverse transcriptase

IDH1:

Isocitrate dehydrogenase 1

IDH2:

Isocitrate dehydrogenase 2

IL-6:

Interleukin 6

JNK:

C-Jun N-terminal kinase

LDH:

Lactate dehydrogenase

LSC:

Leukemic stem cells

MAPK:

Mitogen-activated protein kinase

MDSC:

Myeloid-derived suppressor cell

mROS:

Mitochondrial reactive oxygen species

mtDNA:

Mitochondrial DNA

NADH:

Nicotinamide adenine dinucleotide

NF-κB:

Nuclear factor kappa-light-chain-enhancer of activated B cells

NO:

Nitrogen oxide

NOS:

Nitric oxide synthase

NOX:

NADPH oxidase

NRF2:

Nuclear factor erythroid 2-related factor 2

O2•:

Superoxide

OH•:

Hydroxy radical

OXPHOS:

Oxidative phosphorylation

PRX:

Peroxiredoxins

PDAC:

Pancreatic ductal adenocarcinoma

PD-1:

Programmed death protein 1

PD-L1:

Programmed death ligand 1

PD-L2:

Programmed death ligand 2

PDGFR:

Platelet-derived growth factor receptors

PDGF:

Platelet-derived growth factor receptors

PI3K:

Phosphoinositide 3-kinases

PML:

Promyelocytic leukemia

PTEN:

Phosphatase and tensin homolog

RTK:

Receptor tyrosine kinase

RNS:

Reactive nitrogen species

ROS:

Reactive oxygen species

SAL:

Salvicine

SOD:

Superoxide dismutase

SSZ:

Sulfasalazine

STAT3:

Signal transducer and activator of transcription 3

TF:

Transcription factor

Treg:

Regulatory T cells

TAM:

Tumor-associated macrophages

TFAM:

Mitochondrial transcription factor A

TMZ:

Temozolomide

TNBC:

Triple-negative breast cancer

UCP-2:

Uncoupling protein 2

References

  1. Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12:931–947

    CAS  Google Scholar 

  2. D'Autreaux B, Toledano MB (2007) ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8:813–824

    CAS  Google Scholar 

  3. Handy DE, Loscalzo J (2012) Redox regulation of mitochondrial function. Antioxid Redox Signal 16:1323–1367

    CAS  Google Scholar 

  4. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, McCord JM, Harman D (1987) Oxygen radicals and human disease. Ann Intern Med 107:526–545

    CAS  Google Scholar 

  5. Brewer TF, Garcia FJ, Onak CS, Carroll KS, Chang CJ (2015) Chemical approaches to discovery and study of sources and targets of hydrogen peroxide redox signaling through NADPH oxidase proteins. Annu Rev Biochem 84:765–790

    CAS  Google Scholar 

  6. Glasauer A, Chandel NS (2013) Ros. Curr Biol 23:R100–102

    CAS  Google Scholar 

  7. Sena LA, Chandel NS (2012) Physiological roles of mitochondrial reactive oxygen species. Mol Cell 48:158–167

    CAS  Google Scholar 

  8. Malhotra JD, Kaufman RJ (2007) Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal 9:2277–2293

    CAS  Google Scholar 

  9. Hart PC, Mao M, de Abreu AL, Ansenberger-Fricano K, Ekoue DN, Ganini D, Kajdacsy-Balla A, Diamond AM, Minshall RD, Consolaro ME et al (2015) MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer. Nat Commun 6:6053

    CAS  Google Scholar 

  10. Vignais PV (2002) The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 59:1428–1459

    CAS  Google Scholar 

  11. Rhee SG (2006) Cell signalling. H2O2, a necessary evil for cell signaling. Science 312:1882–1883

    Google Scholar 

  12. Chong SJF, Lai JXH, Eu JQ, Bellot GL, Pervaiz S (2018) Reactive oxygen species and oncoprotein signalling—a dangerous liaison. Antioxid Redox Signal 29:1553–1588

    CAS  Google Scholar 

  13. Pervaiz S (2018) Redox dichotomy in cell fate decision: evasive mechanism or Achilles heel? Antioxid Redox Signal 29:1191–1195

    CAS  Google Scholar 

  14. Reczek CR, Chandel NS (2015) ROS-dependent signal transduction. Curr Opin Cell Biol 33:8–13

    CAS  Google Scholar 

  15. Weinberg F, Chandel NS (2009) Reactive oxygen species-dependent signaling regulates cancer. Cell Mol Life Sci 66:3663–3673

    CAS  Google Scholar 

  16. Sabharwal SS, Schumacker PT (2014) Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nat Rev Cancer 14:709–721

    CAS  Google Scholar 

  17. Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD (2019) ROS and the DNA damage response in cancer. Redox Biol 25:101084

    CAS  Google Scholar 

  18. Somyajit K, Gupta R, Sedlackova H, Neelsen KJ, Ochs F, Rask MB, Choudhary C, Lukas J (2017) Redox-sensitive alteration of replisome architecture safeguards genome integrity. Science 358:797–802

    CAS  Google Scholar 

  19. Sallmyr A, Fan J, Rassool FV (2008) Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair. Cancer Lett 270:1–9

    CAS  Google Scholar 

  20. Rhee SG, Yang KS, Kang SW, Woo HA, Chang TS (2005) Controlled elimination of intracellular H(2)O(2): regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid Redox Signal 7:619–626

    CAS  Google Scholar 

  21. Rhee SG, Woo HA, Kil IS, Bae SH (2012) Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides. J Biol Chem 287:4403–4410

    CAS  Google Scholar 

  22. Chelikani P, Fita I, Loewen PC (2004) Diversity of structures and properties among catalases. Cell Mol Life Sci 61:192–208

    CAS  Google Scholar 

  23. Schieber M, Chandel NS (2014) ROS function in redox signaling and oxidative stress. Curr Biol 24:R453–462

    CAS  Google Scholar 

  24. Raffel J, Bhattacharyya AK, Gallegos A, Cui H, Einspahr JG, Alberts DS, Powis G (2003) Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. J Lab Clin Med 142:46–51

    CAS  Google Scholar 

  25. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, Von Hoff DD (2002) Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 62:2890–2896

    CAS  Google Scholar 

  26. Kim HJ, Chae HZ, Kim YJ, Kim YH, Hwangs TS, Park EM, Park YM (2003) Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues. Cell Biol Toxicol 19:285–298

    CAS  Google Scholar 

  27. Hedley D, Pintilie M, Woo J, Nicklee T, Morrison A, Birle D, Fyles A, Milosevic M, Hill R (2004) Up-regulation of the redox mediators thioredoxin and apurinic/apyrimidinic excision (APE)/Ref-1 in hypoxic microregions of invasive cervical carcinomas, mapped using multispectral, wide-field fluorescence image analysis. Am J Pathol 164:557–565

    CAS  Google Scholar 

  28. Choi JH, Kim TN, Kim S, Baek SH, Kim JH, Lee SR, Kim JR (2002) Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res 22:3331–3335

    CAS  Google Scholar 

  29. Cha MK, Suh KH, Kim IH (2009) Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma. J Exp Clin Cancer Res 28:93

    Google Scholar 

  30. Harris IS, Treloar AE, Inoue S, Sasaki M, Gorrini C, Lee KC, Yung KY, Brenner D, Knobbe-Thomsen CB, Cox MA et al (2015) Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27:211–222

    CAS  Google Scholar 

  31. Desideri E, Ciccarone F, Ciriolo MR (2019) Targeting glutathione metabolism: partner in crime in anticancer therapy. Nutrients 11:1926

    CAS  Google Scholar 

  32. Ryu CS, Kwak HC, Lee JY, Oh SJ, Phuong NT, Kang KW, Kim SK (2013) Elevation of cysteine consumption in tamoxifen-resistant MCF-7 cells. Biochem Pharmacol 85:197–206

    CAS  Google Scholar 

  33. Chatterjee A, Gupta S (2018) The multifaceted role of glutathione S-transferases in cancer. Cancer Lett 433:33–42

    CAS  Google Scholar 

  34. Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88

    CAS  Google Scholar 

  35. Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC (2004) Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal 6:289–300

    CAS  Google Scholar 

  36. Tonelli C, Chio IIC, Tuveson DA (2018) Transcriptional regulation by Nrf2. Antioxid Redox Signal 29:1727–1745

    CAS  Google Scholar 

  37. Chandel NS, Tuveson DA (2014) The promise and perils of antioxidants for cancer patients. N Engl J Med 371:177–178

    CAS  Google Scholar 

  38. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M (2000) Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275:16023–16029

    CAS  Google Scholar 

  39. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13:76–86

    CAS  Google Scholar 

  40. DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES et al (2011) Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475:106–109

    CAS  Google Scholar 

  41. Jaramillo MC, Zhang DD (2013) The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev 27:2179–2191

    CAS  Google Scholar 

  42. Wu KC, Cui JY, Klaassen CD (2011) Beneficial role of Nrf2 in regulating NADPH generation and consumption. Toxicol Sci 123:590–600

    CAS  Google Scholar 

  43. Kerins MJ, Ooi A (2018) A catalogue of somatic NRF2 gain-of-function mutations in cancer. Sci Rep 8:12846

    Google Scholar 

  44. Zhang P, Singh A, Yegnasubramanian S, Esopi D, Kombairaju P, Bodas M, Wu H, Bova SG, Biswal S (2010) Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol Cancer Ther 9:336–346

    CAS  Google Scholar 

  45. Almeida M, Soares M, Ramalhinho AC, Moutinho JF, Breitenfeld L, Pereira L (2020) The prognostic value of NRF2 in breast cancer patients: a systematic review with meta-analysis. Breast Cancer Res Treat 179:523–532

    CAS  Google Scholar 

  46. Rojo de la Vega M, Chapman E, Zhang DD (2018) NRF2 and the hallmarks of cancer. Cancer Cell 34:21–43

    CAS  Google Scholar 

  47. Satoh H, Moriguchi T, Takai J, Ebina M, Yamamoto M (2013) Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. Cancer Res 73:4158–4168

    CAS  Google Scholar 

  48. Garg M, Okamoto R, Nagata Y, Kanojia D, Venkatesan S, Anand MT, Braunstein GD, Said JW, Doan NB, Ho Q et al (2015) Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer cell lines and their genomic evolution over a year as a primagraft. J Clin Endocrinol Metab 100:725–735

    CAS  Google Scholar 

  49. Wang XJ, Sun Z, Villeneuve NF, Zhang S, Zhao F, Li Y, Chen W, Yi X, Zheng W, Wondrak GT et al (2008) Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29:1235–1243

    CAS  Google Scholar 

  50. Benhar M, Shytaj IL, Stamler JS, Savarino A (2016) Dual targeting of the thioredoxin and glutathione systems in cancer and HIV. J Clin Invest 126:1630–1639

    Google Scholar 

  51. Dixon SJ (2017) Ferroptosis: bug or feature? Immunol Rev 277:150–157

    CAS  Google Scholar 

  52. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060–1072

    CAS  Google Scholar 

  53. Gaschler MM, Andia AA, Liu H, Csuka JM, Hurlocker B, Vaiana CA, Heindel DW, Zuckerman DS, Bos PH, Reznik E et al (2018) FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol 14:507–515

    CAS  Google Scholar 

  54. Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, Kang R, Tang D (2016) Ferroptosis: process and function. Cell Death Differ 23:369–379

    CAS  Google Scholar 

  55. Stockwell BR (2019) A powerful cell-protection system prevents cell death by ferroptosis. Nature 575:597–598

    CAS  Google Scholar 

  56. Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch A, Eggenhofer E et al (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 16:1180–1191

    CAS  Google Scholar 

  57. Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156:317–331

    CAS  Google Scholar 

  58. Yang WS, Stockwell BR (2008) Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol 15:234–245

    CAS  Google Scholar 

  59. Shimada K, Skouta R, Kaplan A, Yang WS, Hayano M, Dixon SJ, Brown LM, Valenzuela CA, Wolpaw AJ, Stockwell BR (2016) Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol 12:497–503

    CAS  Google Scholar 

  60. Muller T, Dewitz C, Schmitz J, Schroder AS, Brasen JH, Stockwell BR, Murphy JM, Kunzendorf U, Krautwald S (2017) Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure. Cell Mol Life Sci 74:3631–3645

    Google Scholar 

  61. Yang WS, Stockwell BR (2016) Ferroptosis: death by lipid peroxidation. Trends Cell Biol 26:165–176

    CAS  Google Scholar 

  62. Bridges RJ, Natale NR, Patel SA (2012) System xc(–) cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol 165:20–34

    CAS  Google Scholar 

  63. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

    Google Scholar 

  64. Garg M, Braunstein G, Koeffler HP (2014) LAMC2 as a therapeutic target for cancers. Expert Opin Ther Targets 18:979–982

    CAS  Google Scholar 

  65. Bishayee A, Sethi G (2016) Bioactive natural products in cancer prevention and therapy: progress and promise. Semin Cancer Biol 40–41:1–3

    Google Scholar 

  66. Shanmugam MK, Lee JH, Chai EZ, Kanchi MM, Kar S, Arfuso F, Dharmarajan A, Kumar AP, Ramar PS, Looi CY et al (2016) Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds. Semin Cancer Biol 40–41:35–47

    Google Scholar 

  67. Shanmugam MK, Warrier S, Kumar AP, Sethi G, Arfuso F (2017) Potential role of natural compounds as anti-angiogenic agents in cancer. Curr Vasc Pharmacol 15:503–519

    CAS  Google Scholar 

  68. Purohit V, Simeone DM, Lyssiotis CA (2019) Metabolic regulation of redox balance in cancer. Cancers (Basel) 11:955

    CAS  Google Scholar 

  69. Oberley LW (1988) Free radicals and diabetes. Free Radic Biol Med 5:113–124

    CAS  Google Scholar 

  70. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, Rhee SG (1997) Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272:217–221

    CAS  Google Scholar 

  71. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270:296–299

    CAS  Google Scholar 

  72. Seth D, Rudolph J (2006) Redox regulation of MAP kinase phosphatase 3. Biochemistry 45:8476–8487

    CAS  Google Scholar 

  73. Son Y, Cheong YK, Kim NH, Chung HT, Kang DG, Pae HO (2011) Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways? J Signal Transduct 2011:792639

    Google Scholar 

  74. Sidhanth C, Manasa P, Krishnapriya S, Sneha S, Bindhya S, Nagare RP, Garg M, Ganesan TS (2018) A systematic understanding of signaling by ErbB2 in cancer using phosphoproteomics. Biochem Cell Biol 96:295–305

    CAS  Google Scholar 

  75. Park KR, Nam D, Yun HM, Lee SG, Jang HJ, Sethi G, Cho SK, Ahn KS (2011) beta-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Lett 312:178–188

    CAS  Google Scholar 

  76. Lee JH, Kim C, Lee SG, Yang WM, Um JY, Sethi G, Ahn KS (2018) Ophiopogonin D modulates multiple oncogenic signaling pathways, leading to suppression of proliferation and chemosensitization of human lung cancer cells. Phytomedicine 40:165–175

    CAS  Google Scholar 

  77. Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, Varol M, Jain A, Khan MA, Sethi G (2019) Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules 9:735

    CAS  Google Scholar 

  78. Rana R, Jagadish N, Garg M, Mishra D, Dahiya N, Chaurasiya D, Suri A (2006) Small interference RNA-mediated knockdown of sperm associated antigen 9 having structural homology with c-Jun N-terminal kinase-interacting protein. Biochem Biophys Res Commun 340:158–164

    CAS  Google Scholar 

  79. Meves A, Stock SN, Beyerle A, Pittelkow MR, Peus D (2001) H(2)O(2) mediates oxidative stress-induced epidermal growth factor receptor phosphorylation. Toxicol Lett 122:205–214

    CAS  Google Scholar 

  80. Kanojia D, Garg M, Martinez J, Luty SB, Doan NB, Said JW, Forscher C, Tyner JW, Koeffler HP (2017) Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets. J Hematol Oncol 10:173

    Google Scholar 

  81. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ (1997) Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275:1649–1652

    CAS  Google Scholar 

  82. Messina S, De Simone G, Ascenzi P (2019) Cysteine-based regulation of redox-sensitive Ras small GTPases. Redox Biol 26:101282

    CAS  Google Scholar 

  83. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger GR, Chandel NS (2010) Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A 107:8788–8793

    CAS  Google Scholar 

  84. Woo DK, Green PD, Santos JH, D'Souza AD, Walther Z, Martin WD, Christian BE, Chandel NS, Shadel GS (2012) Mitochondrial genome instability and ROS enhance intestinal tumorigenesis in APC(Min/+) mice. Am J Pathol 180:24–31

    CAS  Google Scholar 

  85. Liou GY, Doppler H, DelGiorno KE, Zhang L, Leitges M, Crawford HC, Murphy MP, Storz P (2016) Mutant KRas-induced Mitochondrial oxidative stress in acinar cells upregulates EGFR signaling to drive formation of pancreatic precancerous lesions. Cell Rep 14:2325–2336

    CAS  Google Scholar 

  86. Shi X, Zhang Y, Zheng J, Pan J (2012) Reactive oxygen species in cancer stem cells. Antioxid Redox Signal 16:1215–1228

    CAS  Google Scholar 

  87. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275:90–94

    CAS  Google Scholar 

  88. Moon DO, Kim MO, Choi YH, Hyun JW, Chang WY, Kim GY (2010) Butein induces G(2)/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation. Cancer Lett 288:204–213

    CAS  Google Scholar 

  89. Lee S, Kim SM, Lee RT (2013) Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance. Antioxid Redox Signal 18:1165–1207

    CAS  Google Scholar 

  90. Yin Z, Ivanov VN, Habelhah H, Tew K, Ronai Z (2000) Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases. Cancer Res 60:4053–4057

    CAS  Google Scholar 

  91. Dolado I, Swat A, Ajenjo N, De Vita G, Cuadrado A, Nebreda AR (2007) p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 11:191–205

    CAS  Google Scholar 

  92. Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9:537–549

    CAS  Google Scholar 

  93. Koundouros N, Poulogiannis G (2018) Phosphoinositide 3-kinase/Akt signaling and redox metabolism in cancer. Front Oncol 8:160

    Google Scholar 

  94. Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, Barford D (2003) Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423:769–773

    CAS  Google Scholar 

  95. Lee SR, Yang KS, Kwon J, Lee C, Jeong W, Rhee SG (2002) Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 277:20336–20342

    CAS  Google Scholar 

  96. Baek SH, Ko JH, Lee JH, Kim C, Lee H, Nam D, Lee J, Lee SG, Yang WM, Um JY et al (2017) Ginkgolic acid inhibits invasion and migration and TGF-beta-induced EMT of lung cancer cells through PI3K/Akt/mTOR inactivation. J Cell Physiol 232:346–354

    CAS  Google Scholar 

  97. Siveen KS, Ahn KS, Ong TH, Shanmugam MK, Li F, Yap WN, Kumar AP, Fong CW, Tergaonkar V, Hui KM, Sethi G (2014) Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model. Oncotarget 5:1897–1911

    Google Scholar 

  98. Wu H, Goel V, Haluska FG (2003) PTEN signaling pathways in melanoma. Oncogene 22:3113–3122

    CAS  Google Scholar 

  99. Behrend L, Henderson G, Zwacka RM (2003) Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 31:1441–1444

    CAS  Google Scholar 

  100. Ding LW, Sun QY, Lin DC, Chien W, Hattori N, Dong XM, Gery S, Garg M, Doan NB, Said JW et al (2015) LNK (SH2B3): paradoxical effects in ovarian cancer. Oncogene 34:1463–1474

    CAS  Google Scholar 

  101. Nakaso K, Yano H, Fukuhara Y, Takeshima T, Wada-Isoe K, Nakashima K (2003) PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett 546:181–184

    CAS  Google Scholar 

  102. Gorrini C, Gang BP, Bassi C, Wakeham A, Baniasadi SP, Hao Z, Li WY, Cescon DW, Li YT, Molyneux S et al (2014) Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated pathway. Proc Natl Acad Sci U S A 111:4472–4477

    CAS  Google Scholar 

  103. Shin EM, Hay HS, Lee MH, Goh JN, Tan TZ, Sen YP, Lim SW, Yousef EM, Ong HT, Thike AA et al (2014) DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest 124:3807–3824

    CAS  Google Scholar 

  104. Manu KA, Shanmugam MK, Ramachandran L, Li F, Siveen KS, Chinnathambi A, Zayed ME, Alharbi SA, Arfuso F, Kumar AP et al (2015) Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-kappaB signaling cascade in gastric cancer. Cancer Lett 363:28–36

    CAS  Google Scholar 

  105. Li F, Zhang J, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Kumar AP, Ahn KS, Sethi G (2015) NF-kappaB in cancer therapy. Arch Toxicol 89:711–731

    CAS  Google Scholar 

  106. Manu KA, Shanmugam MK, Ramachandran L, Li F, Fong CW, Kumar AP, Tan P, Sethi G (2012) First evidence that gamma-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-kappaB pathway. Clin Cancer Res 18:2220–2229

    CAS  Google Scholar 

  107. Manu KA, Shanmugam MK, Rajendran P, Li F, Ramachandran L, Hay HS, Kannaiyan R, Swamy SN, Vali S, Kapoor S et al (2011) Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4. Mol Cancer 10:107

    CAS  Google Scholar 

  108. Morgan MJ, Liu ZG (2011) Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res 21:103–115

    CAS  Google Scholar 

  109. Ruiz-Ramos R, Lopez-Carrillo L, Rios-Perez AD, De Vizcaya-Ruiz A, Cebrian ME (2009) Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-Myc proteins, NF-kappaB activation and cell proliferation in human breast cancer MCF-7 cells. Mutat Res 674:109–115

    CAS  Google Scholar 

  110. Li Q, Engelhardt JF (2006) Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase. J Biol Chem 281:1495–1505

    CAS  Google Scholar 

  111. Kobayashi M, Yamamoto M (2006) Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv Enzyme Regul 46:113–140

    CAS  Google Scholar 

  112. Lee M, Hirpara JL, Eu JQ, Sethi G, Wang L, Goh BC, Wong AL (2018) Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors. Redox Biol 25:101073

    Google Scholar 

  113. Kim C, Lee SG, Yang WM, Arfuso F, Um JY, Kumar AP, Bian J, Sethi G, Ahn KS (2018) Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model. Cancer Lett 431:123–141

    CAS  Google Scholar 

  114. Sethi G, Chatterjee S, Rajendran P, Li F, Shanmugam MK, Wong KF, Kumar AP, Senapati P, Behera AK, Hui KM et al (2014) Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo. Mol Cancer 13:66

    Google Scholar 

  115. Arora L, Kumar AP, Arfuso F, Chng WJ, Sethi G (2018) The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies. Cancers (Basel) 10:327

    Google Scholar 

  116. Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Sethi G (2012) Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. J Cell Physiol 227:2184–2195

    CAS  Google Scholar 

  117. Su WP, Lo YC, Yan JJ, Liao IC, Tsai PJ, Wang HC, Yeh HH, Lin CC, Chen HH, Lai WW, Su WC (2012) Mitochondrial uncoupling protein 2 regulates the effects of paclitaxel on Stat3 activation and cellular survival in lung cancer cells. Carcinogenesis 33:2065–2075

    CAS  Google Scholar 

  118. Lu L, Dong J, Wang L, Xia Q, Zhang D, Kim H, Yin T, Fan S, Shen Q (2018) Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide. Oncogene 37:5292–5304

    CAS  Google Scholar 

  119. Li J, Lan T, Zhang C, Zeng C, Hou J, Yang Z, Zhang M, Liu J, Liu B (2015) Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells. Oncotarget 6:1031–1048

    Google Scholar 

  120. Stanicka J, Russell EG, Woolley JF, Cotter TG (2015) NADPH oxidase-generated hydrogen peroxide induces DNA damage in mutant FLT3-expressing leukemia cells. J Biol Chem 290:9348–9361

    CAS  Google Scholar 

  121. Woolley JF, Naughton R, Stanicka J, Gough DR, Bhatt L, Dickinson BC, Chang CJ, Cotter TG (2012) H2O2 production downstream of FLT3 is mediated by p22phox in the endoplasmic reticulum and is required for STAT5 signalling. PLoS ONE 7:e34050

    CAS  Google Scholar 

  122. Warsch W, Grundschober E, Berger A, Gille L, Cerny-Reiterer S, Tigan AS, Hoelbl-Kovacic A, Valent P, Moriggl R, Sexl V (2012) STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia. Oncotarget 3:1669–1687

    Google Scholar 

  123. Santos JH, Meyer JN, Van Houten B (2006) Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis. Hum Mol Genet 15:1757–1768

    CAS  Google Scholar 

  124. Li Y, Cheng HS, Chng WJ, Tergaonkar V (2016) Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas. Proc Natl Acad Sci U S A 113:14402–14407

    CAS  Google Scholar 

  125. Sharma NK, Reyes A, Green P, Caron MJ, Bonini MG, Gordon DM, Holt IJ, Santos JH (2012) Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria. Nucleic Acids Res 40:712–725

    CAS  Google Scholar 

  126. Khattar E, Kumar P, Liu CY, Akincilar SC, Raju A, Lakshmanan M, Maury JJ, Qiang Y, Li S, Tan EY et al (2016) Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression. J Clin Invest 126:4045–4060

    Google Scholar 

  127. Akincilar SC, Khattar E, Boon PL, Unal B, Fullwood MJ, Tergaonkar V (2016) Long-range chromatin interactions drive mutant TERT promoter activation. Cancer Discov 6:1276–1291

    CAS  Google Scholar 

  128. Akincilar SC, Low KC, Liu CY, Yan TD, Oji A, Ikawa M, Li S, Tergaonkar V (2015) Quantitative assessment of telomerase components in cancer cell lines. FEBS Lett 589:974–984

    CAS  Google Scholar 

  129. Ko E, Seo HW, Jung G (2018) Telomere length and reactive oxygen species levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma. Hepatology 67:1378–1391

    CAS  Google Scholar 

  130. Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G (2008) Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 135:2128–2140

    CAS  Google Scholar 

  131. Low KC, Tergaonkar V (2013) Telomerase: central regulator of all of the hallmarks of cancer. Trends Biochem Sci 38:426–434

    CAS  Google Scholar 

  132. Lipinska N, Romaniuk A, Paszel-Jaworska A, Toton E, Kopczynski P, Rubis B (2017) Telomerase and drug resistance in cancer. Cell Mol Life Sci 74:4121–4132

    CAS  Google Scholar 

  133. Ziech D, Franco R, Pappa A, Panayiotidis MI (2011) Reactive oxygen species (ROS)–induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 711:167–173

    CAS  Google Scholar 

  134. von Zglinicki T (2002) Oxidative stress shortens telomeres. Trends Biochem Sci 27:339–344

    Google Scholar 

  135. Peiris-Pages M, Martinez-Outschoorn UE, Sotgia F, Lisanti MP (2015) Metastasis and oxidative stress: are antioxidants a metabolic driver of progression? Cell Metab 22:956–958

    CAS  Google Scholar 

  136. Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, Leitch AM, Johnson TM, DeBerardinis RJ, Morrison SJ (2015) Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527:186–191

    CAS  Google Scholar 

  137. Tobar N, Villar V, Santibanez JF (2010) ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol Cell Biochem 340:195–202

    CAS  Google Scholar 

  138. Kim MC, Cui FJ, Kim Y (2013) Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells. Asian Pac J Cancer Prev 14:3625–3630

    Google Scholar 

  139. Qu Y, Wang J, Ray PS, Guo H, Huang J, Shin-Sim M, Bukoye BA, Liu B, Lee AV, Lin X et al (2011) Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-kappaB signaling. J Clin Invest 121:212–225

    CAS  Google Scholar 

  140. Prabhakar NR, Semenza GL (2015) Oxygen sensing and homeostasis. Physiology (Bethesda) 30:340–348

    CAS  Google Scholar 

  141. Pugh CW, Ratcliffe PJ (2017) New horizons in hypoxia signaling pathways. Exp Cell Res 356:116–121

    CAS  Google Scholar 

  142. Liu LZ, Hu XW, Xia C, He J, Zhou Q, Shi X, Fang J, Jiang BH (2006) Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic Biol Med 41:1521–1533

    CAS  Google Scholar 

  143. Govindarajan B, Sligh JE, Vincent BJ, Li M, Canter JA, Nickoloff BJ, Rodenburg RJ, Smeitink JA, Oberley L, Zhang Y et al (2007) Overexpression of Akt converts radial growth melanoma to vertical growth melanoma. J Clin Invest 117:719–729

    CAS  Google Scholar 

  144. Dewhirst MW, Cao Y, Moeller B (2008) Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8:425–437

    CAS  Google Scholar 

  145. Sancho P, Barneda D, Heeschen C (2016) Hallmarks of cancer stem cell metabolism. Br J Cancer 114:1305–1312

    CAS  Google Scholar 

  146. Xu B, Wang S, Li R, Chen K, He L, Deng M, Kannappan V, Zha J, Dong H, Wang W (2017) Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-kappaB and Nrf2. Cell Death Dis 8:e2797

    CAS  Google Scholar 

  147. Giambra V, Jenkins CR, Wang H, Lam SH, Shevchuk OO, Nemirovsky O, Wai C, Gusscott S, Chiang MY, Aster JC et al (2012) NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-theta and reactive oxygen species. Nat Med 18:1693–1698

    CAS  Google Scholar 

  148. Herault O, Hope KJ, Deneault E, Mayotte N, Chagraoui J, Wilhelm BT, Cellot S, Sauvageau M, Andrade-Navarro MA, Hebert J, Sauvageau G (2012) A role for GPx3 in activity of normal and leukemia stem cells. J Exp Med 209:895–901

    CAS  Google Scholar 

  149. Dong C, Yuan T, Wu Y, Wang Y, Fan TW, Miriyala S, Lin Y, Yao J, Shi J, Kang T et al (2013) Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 23:316–331

    CAS  Google Scholar 

  150. Hirpara J, Eu JQ, Tan JKM, Wong AL, Clement MV, Kong LR, Ohi N, Tsunoda T, Qu J, Goh BC, Pervaiz S (2018) Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance. Redox Biol 25:101076

    Google Scholar 

  151. Wang C, Shao L, Pan C, Ye J, Ding Z, Wu J, Du Q, Ren Y, Zhu C (2019) Elevated level of mitochondrial reactive oxygen species via fatty acid beta-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition. Stem Cell Res Ther 10:175

    Google Scholar 

  152. Pervaiz S (2019) Cell signaling and fate through the redox lens. Redox Biol 25:101298

    CAS  Google Scholar 

  153. Sena LA, Li S, Jairaman A, Prakriya M, Ezponda T, Hildeman DA, Wang CR, Schumacker PT, Licht JD, Perlman H et al (2013) Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38:225–236

    CAS  Google Scholar 

  154. Kaminski M, Kiessling M, Suss D, Krammer PH, Gulow K (2007) Novel role for mitochondria: protein kinase Ctheta-dependent oxidative signaling organelles in activation-induced T-cell death. Mol Cell Biol 27:3625–3639

    CAS  Google Scholar 

  155. Warrier VU, Makandar AI, Garg M, Sethi G, Kant R, Pal JK, Yuba E (2019) Engineering anti-cancer nanovaccine based on antigen cross-presentation. Biosci Rep 39:BSR20193220

    CAS  Google Scholar 

  156. Scharping NE, Menk AV, Moreci RS, Whetstone RD, Dadey RE, Watkins SC, Ferris RL, Delgoffe GM (2016) The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45:701–703

    CAS  Google Scholar 

  157. Siska PJ, Beckermann KE, Mason FM, Andrejeva G, Greenplate AR, Sendor AB, Chiang YJ, Corona AL, Gemta LF, Vincent BG et al (2017) Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. JCI Insight 2:e93411

    Google Scholar 

  158. Ligtenberg MA, Mougiakakos D, Mukhopadhyay M, Witt K, Lladser A, Chmielewski M, Riet T, Abken H, Kiessling R (2016) Coexpressed catalase protects chimeric antigen receptor-redirected T cells as well as bystander cells from oxidative stress-induced loss of antitumor activity. J Immunol 196:759–766

    CAS  Google Scholar 

  159. Zhou X, Chen J, Yi G, Deng M, Liu H, Liang M, Shi B, Fu X, Chen Y, Chen L et al (2016) Metformin suppresses hypoxia-induced stabilization of HIF-1alpha through reprogramming of oxygen metabolism in hepatocellular carcinoma. Oncotarget 7:873–884

    Google Scholar 

  160. Scharping NE, Menk AV, Whetstone RD, Zeng X, Delgoffe GM (2017) Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia. Cancer Immunol Res 5:9–16

    CAS  Google Scholar 

  161. Kunisada Y, Eikawa S, Tomonobu N, Domae S, Uehara T, Hori S, Furusawa Y, Hase K, Sasaki A, Udono H (2017) Attenuation of CD4(+)CD25(+) regulatory T cells in the tumor microenvironment by metformin, a type 2 diabetes drug. EBioMedicine 25:154–164

    Google Scholar 

  162. Weinberg SE, Singer BD, Steinert EM, Martinez CA, Mehta MM, Martinez-Reyes I, Gao P, Helmin KA, Abdala-Valencia H, Sena LA et al (2019) Mitochondrial complex III is essential for suppressive function of regulatory T cells. Nature 565:495–499

    CAS  Google Scholar 

  163. OuYang LY, Wu XJ, Ye SB, Zhang RX, Li ZL, Liao W, Pan ZZ, Zheng LM, Zhang XS, Wang Z et al (2015) Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer. J Transl Med 13:47

    Google Scholar 

  164. Wei J, Zhang M, Zhou J (2015) Myeloid-derived suppressor cells in major depression patients suppress T cell responses through the production of reactive oxygen species. Psychiatry Res 228:695–701

    CAS  Google Scholar 

  165. Weinberg SE, Sena LA, Chandel NS (2015) Mitochondria in the regulation of innate and adaptive immunity. Immunity 42:406–417

    CAS  Google Scholar 

  166. Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, van den Berg JM, Ottenhoff TH, Kuijpers TW, Holmdahl R, van Kooten C, Gelderman KA (2010) Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci U S A 107:17686–17691

    CAS  Google Scholar 

  167. Lin X, Zheng W, Liu J, Zhang Y, Qin H, Wu H, Xue B, Lu Y, Shen P (2013) Oxidative stress in malignant melanoma enhances tumor necrosis factor-alpha secretion of tumor-associated macrophages that promote cancer cell invasion. Antioxid Redox Signal 19:1337–1355

    CAS  Google Scholar 

  168. Garrett WS (2015) Cancer and the microbiota. Science 348:80–86

    CAS  Google Scholar 

  169. Weinberg F, Ramnath N, Nagrath D (2019) Reactive oxygen species in the tumor microenvironment: an overview. Cancers (Basel) 11:1191

    CAS  Google Scholar 

  170. Huycke MM, Abrams V, Moore DR (2002) Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 23:529–536

    CAS  Google Scholar 

  171. Goodwin AC, Destefano Shields CE, Wu S, Huso DL, Wu X, Murray-Stewart TR, Hacker-Prietz A, Rabizadeh S, Woster PM, Sears CL, Casero RA Jr (2011) Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci U S A 108:15354–15359

    CAS  Google Scholar 

  172. Bernstein H, Bernstein C, Payne CM, Dvorak K (2009) Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol 15:3329–3340

    CAS  Google Scholar 

  173. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB (2012) Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487:104–108

    CAS  Google Scholar 

  174. Jones RM, Mercante JW, Neish AS (2012) Reactive oxygen production induced by the gut microbiota: pharmacotherapeutic implications. Curr Med Chem 19:1519–1529

    CAS  Google Scholar 

  175. Yardeni T, Tanes CE, Bittinger K, Mattei LM, Schaefer PM, Singh LN, Wu GD, Murdock DG, Wallace DC (2019) Host mitochondria influence gut microbiome diversity: A role for ROS. Sci Signal 12:eaaw3159

    Google Scholar 

  176. Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC et al (2018) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359:97–103

    CAS  Google Scholar 

  177. O'Dwyer PJ, Hamilton TC, LaCreta FP, Gallo JM, Kilpatrick D, Halbherr T, Brennan J, Bookman MA, Hoffman J, Young RC et al (1996) Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. J Clin Oncol 14:249–256

    CAS  Google Scholar 

  178. Lewis-Wambi JS, Kim HR, Wambi C, Patel R, Pyle JR, Klein-Szanto AJ, Jordan VC (2008) Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis. Breast Cancer Res 10:R104

    Google Scholar 

  179. Gupta P, Wright SE, Kim SH, Srivastava SK (2014) Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms. Biochim Biophys Acta 1846:405–424

    CAS  Google Scholar 

  180. Townsend DM, Tew KD (2009) Pharmacology of a mimetic of glutathione disulfide, NOV-002. Biomed Pharmacother 63:75–78

    CAS  Google Scholar 

  181. Montero AJ, Diaz-Montero CM, Deutsch YE, Hurley J, Koniaris LG, Rumboldt T, Yasir S, Jorda M, Garret-Mayer E, Avisar E et al (2012) Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer. Breast Cancer Res Treat 132:215–223

    CAS  Google Scholar 

  182. Sobhakumari A, Love-Homan L, Fletcher EV, Martin SM, Parsons AD, Spitz DR, Knudson CM, Simons AL (2012) Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism. PLoS ONE 7:e48175

    CAS  Google Scholar 

  183. Marzano C, Gandin V, Folda A, Scutari G, Bindoli A, Rigobello MP (2007) Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells. Free Radic Biol Med 42:872–881

    CAS  Google Scholar 

  184. Habermann KJ, Grunewald L, van Wijk S, Fulda S (2017) Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death. Cell Death Dis 8:e3067

    Google Scholar 

  185. Hou GX, Liu PP, Zhang S, Yang M, Liao J, Yang J, Hu Y, Jiang WQ, Wen S, Huang P (2018) Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis. Cell Death Dis 9:89

    Google Scholar 

  186. Zhou J, Bi C, Cheong LL, Mahara S, Liu SC, Tay KG, Koh TL, Yu Q, Chng WJ (2011) The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML. Blood 118:2830–2839

    Google Scholar 

  187. Valenzuela M, Glorieux C, Stockis J, Sid B, Sandoval JM, Felipe KB, Kviecinski MR, Verrax J, Buc Calderon P (2014) Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells. Br J Cancer 111:874–882

    CAS  Google Scholar 

  188. Kim D, Choi BH, Ryoo IG, Kwak MK (2018) High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling. Cell Death Dis 9:896

    Google Scholar 

  189. Bollong MJ, Yun H, Sherwood L, Woods AK, Lairson LL, Schultz PG (2015) A small molecule inhibits deregulated NRF2 transcriptional activity in cancer. ACS Chem Biol 10:2193–2198

    CAS  Google Scholar 

  190. Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, Li B (2019) Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol 12:34

    Google Scholar 

  191. Lachaier E, Louandre C, Godin C, Saidak Z, Baert M, Diouf M, Chauffert B, Galmiche A (2014) Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors. Anticancer Res 34:6417–6422

    CAS  Google Scholar 

  192. Eling N, Reuter L, Hazin J, Hamacher-Brady A, Brady NR (2015) Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience 2:517–532

    Google Scholar 

  193. Roh JL, Kim EH, Jang H, Shin D (2017) Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biol 11:254–262

    CAS  Google Scholar 

  194. Patel D, Kharkar PS, Gandhi NS, Kaur E, Dutt S, Nandave M (2019) Novel analogs of sulfasalazine as system xc(–) antiporter inhibitors: Insights from the molecular modeling studies. Drug Dev Res 80:758–777

    CAS  Google Scholar 

  195. Lo M, Ling V, Low C, Wang YZ, Gout PW (2010) Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer. Curr Oncol 17:9–16

    CAS  Google Scholar 

  196. Guan J, Lo M, Dockery P, Mahon S, Karp CM, Buckley AR, Lam S, Gout PW, Wang YZ (2009) The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine. Cancer Chemother Pharmacol 64:463–472

    CAS  Google Scholar 

  197. Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS, Stockwell BR (2014) Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife 3:e02523

    Google Scholar 

  198. Sehm T, Fan Z, Ghoochani A, Rauh M, Engelhorn T, Minakaki G, Dorfler A, Klucken J, Buchfelder M, Eyupoglu IY, Savaskan N (2016) Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema. Oncotarget 7:36021–36033

    Google Scholar 

  199. Buccarelli M, Marconi M, Pacioni S, De Pascalis I, D'Alessandris QG, Martini M, Ascione B, Malorni W, Larocca LM, Pallini R et al (2018) Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis. Cell Death Dis 9:841

    Google Scholar 

  200. Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C, Dai X, Li Z, Wu G (2018) Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res Treat 50:445–460

    CAS  Google Scholar 

  201. Shaw AT, Winslow MM, Magendantz M, Ouyang C, Dowdle J, Subramanian A, Lewis TA, Maglathin RL, Tolliday N, Jacks T (2011) Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress. Proc Natl Acad Sci U S A 108:8773–8778

    CAS  Google Scholar 

  202. Mai TT, Hamai A, Hienzsch A, Caneque T, Muller S, Wicinski J, Cabaud O, Leroy C, David A, Acevedo V et al (2017) Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Nat Chem 9:1025–1033

    CAS  Google Scholar 

  203. Klose J, Trefz S, Wagner T, Steffen L, Preissendorfer Charrier A, Radhakrishnan P, Volz C, Schmidt T, Ulrich A, Dieter SM et al (2019) Salinomycin: anti-tumor activity in a pre-clinical colorectal cancer model. PLoS ONE 14:e0211916

    CAS  Google Scholar 

  204. Zilka O, Shah R, Li B, Friedmann Angeli JP, Griesser M, Conrad M, Pratt DA (2017) On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent Sci 3:232–243

    CAS  Google Scholar 

  205. Cao JY, Dixon SJ (2016) Mechanisms of ferroptosis. Cell Mol Life Sci 73:2195–2209

    CAS  Google Scholar 

  206. Ye J, Zhang R, Wu F, Zhai L, Wang K, Xiao M, Xie T, Sui X (2018) Non-apoptotic cell death in malignant tumor cells and natural compounds. Cancer Lett 420:210–227

    CAS  Google Scholar 

  207. Park S, Oh J, Kim M, Jin EJ (2018) Bromelain effectively suppresses Kras-mutant colorectal cancer by stimulating ferroptosis. Anim Cells Syst (Seoul) 22:334–340

    CAS  Google Scholar 

  208. Kasukabe T, Honma Y, Okabe-Kado J, Higuchi Y, Kato N, Kumakura S (2016) Combined treatment with cotylenin A and phenethyl isothiocyanate induces strong antitumor activity mainly through the induction of ferroptotic cell death in human pancreatic cancer cells. Oncol Rep 36:968–976

    CAS  Google Scholar 

  209. Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB et al (2017) Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol 13:81–90

    CAS  Google Scholar 

  210. Garg M, Nagata Y, Kanojia D, Mayakonda A, Yoshida K, Haridas Keloth S, Zang ZJ, Okuno Y, Shiraishi Y, Chiba K et al (2015) Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse. Blood 126:2491–2501

    CAS  Google Scholar 

  211. Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, Anderson KJ, Abiola O, Aldape K, Alfaro KD et al (2019) Longitudinal molecular trajectories of diffuse glioma in adults. Nature 576:112–120

    CAS  Google Scholar 

  212. Chien W, Sun QY, Ding LW, Mayakonda A, Takao S, Liu L, Lim SL, Tan KT, Garg M, Varela ADSM et al (2017) Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD. Leukemia 31:762–766

    CAS  Google Scholar 

  213. Sun QY, Ding LW, Tan KT, Chien W, Mayakonda A, Lin DC, Loh XY, Xiao JF, Meggendorfer M, Alpermann T et al (2017) Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD). Leukemia 31:1–10

    CAS  Google Scholar 

  214. Sasaki M, Knobbe CB, Itsumi M, Elia AJ, Harris IS, Chio II, Cairns RA, McCracken S, Wakeham A, Haight J et al (2012) D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function. Genes Dev 26:2038–2049

    CAS  Google Scholar 

  215. Stein EM, DiNardo CD, Pollyea DA, Fathi AT, Roboz GJ, Altman JK, Stone RM, DeAngelo DJ, Levine RL, Flinn IW et al (2017) Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia. Blood 130:722–731

    CAS  Google Scholar 

  216. Liu P, Brown S, Goktug T, Channathodiyil P, Kannappan V, Hugnot JP, Guichet PO, Bian X, Armesilla AL, Darling JL, Wang W (2012) Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells. Br J Cancer 107:1488–1497

    CAS  Google Scholar 

  217. Jeanne M, Lallemand-Breitenbach V, Ferhi O, Koken M, Le Bras M, Duffort S, Peres L, Berthier C, Soilihi H, Raught B, de The H (2010) PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. Cancer Cell 18:88–98

    CAS  Google Scholar 

  218. Huang W, Zeng YC (2019) A candidate for lung cancer treatment: arsenic trioxide. Clin Transl Oncol 21:1115–1126

    CAS  Google Scholar 

  219. Miller WH Jr, Schipper HM, Lee JS, Singer J, Waxman S (2002) Mechanisms of action of arsenic trioxide. Cancer Res 62:3893–3903

    CAS  Google Scholar 

  220. Bahlis NJ, McCafferty-Grad J, Jordan-McMurry I, Neil J, Reis I, Kharfan-Dabaja M, Eckman J, Goodman M, Fernandez HF, Boise LH, Lee KP (2002) Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma. Clin Cancer Res 8:3658–3668

    CAS  Google Scholar 

  221. Coleman MC, Asbury CR, Daniels D, Du J, Aykin-Burns N, Smith BJ, Li L, Spitz DR, Cullen JJ (2008) 2-Deoxy-d-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer. Free Radic Biol Med 44:322–331

    CAS  Google Scholar 

  222. Lin X, Zhang F, Bradbury CM, Kaushal A, Li L, Spitz DR, Aft RL, Gius D (2003) 2-Deoxy-d-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Res 63:3413–3417

    CAS  Google Scholar 

  223. Ben Sahra I, Laurent K, Giuliano S, Larbret F, Ponzio G, Gounon P, Le Marchand-Brustel Y, Giorgetti-Peraldi S, Cormont M, Bertolotto C et al (2010) Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res 70:2465–2475

    CAS  Google Scholar 

  224. Wang Q, He C (2020) Dietary vitamin A intake and the risk of ovarian cancer: a meta-analysis. Biosci Rep 40:BSR20193979

    CAS  Google Scholar 

  225. Yun J, Mullarky E, Lu C, Bosch KN, Kavalier A, Rivera K, Roper J, Chio II, Giannopoulou EG, Rago C et al (2015) Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science 350:1391–1396

    CAS  Google Scholar 

  226. Grant WB (2020) Review of recent advances in understanding the role of vitamin D in reducing cancer risk: breast, colorectal, prostate, and overall cancer. Anticancer Res 40:491–499

    CAS  Google Scholar 

  227. Yang CS, Wang X, Lu G, Picinich SC (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429–439

    CAS  Google Scholar 

  228. Chien W, Sudo M, Ding LW, Sun QY, Wuensche P, Lee KL, Hattori N, Garg M, Xu L, Zheng Y et al (2018) Functional genome-wide screening identifies targets and pathways sensitizing pancreatic cancer cells to dasatinib. J Cancer 9:4762–4773

    CAS  Google Scholar 

  229. Gahr S, Ocker M, Ganslmayer M, Zopf S, Okamoto K, Hartl A, Leitner S, Hahn EG, Herold C (2007) The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells. Int J Oncol 31:567–576

    CAS  Google Scholar 

  230. Shankar S, Ganapathy S, Hingorani SR, Srivastava RK (2008) EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci 13:440–452

    Google Scholar 

  231. Srivastava SK, Singh SV (2004) Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells. Carcinogenesis 25:1701–1709

    CAS  Google Scholar 

  232. Chien W, Ding LW, Sun QY, Torres-Fernandez LA, Tan SZ, Xiao J, Lim SL, Garg M, Lee KL, Kitajima S et al (2014) Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells. Oncotarget 5:4881–4894

    Google Scholar 

  233. Jagadish N, Rana R, Mishra D, Garg M, Chaurasiya D, Hasegawa A, Koyama K, Suri A (2005) Immunogenicity and contraceptive potential of recombinant human sperm associated antigen (SPAG9). J Reprod Immunol 67:69–76

    CAS  Google Scholar 

  234. Rao CV (2013) Benzyl isothiocyanate: double trouble for breast cancer cells. Cancer Prev Res (Phila) 6:760–763

    CAS  Google Scholar 

  235. Ayyanathan K, Kesaraju S, Dawson-Scully K, Weissbach H (2012) Combination of sulindac and dichloroacetate kills cancer cells via oxidative damage. PLoS ONE 7:e39949

    CAS  Google Scholar 

  236. McLean L, Soto U, Agama K, Francis J, Jimenez R, Pommier Y, Sowers L, Brantley E (2008) Aminoflavone induces oxidative DNA damage and reactive oxidative species-mediated apoptosis in breast cancer cells. Int J Cancer 122:1665–1674

    CAS  Google Scholar 

  237. Woo CC, Hsu A, Kumar AP, Sethi G, Tan KH (2013) Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS. PLoS ONE 8:e75356

    CAS  Google Scholar 

  238. Wang H, Sim MK, Loke WK, Chinnathambi A, Alharbi SA, Tang FR, Sethi G (2017) Potential protective effects of ursolic acid against gamma irradiation-induced damage are mediated through the modulation of diverse inflammatory mediators. Front Pharmacol 8:352

    Google Scholar 

  239. McLachlan A, Kekre N, McNulty J, Pandey S (2005) Pancratistatin: a natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis. Apoptosis 10:619–630

    CAS  Google Scholar 

  240. Chen J, Wanming D, Zhang D, Liu Q, Kang J (2005) Water-soluble antioxidants improve the antioxidant and anticancer activity of low concentrations of curcumin in human leukemia cells. Pharmazie 60:57–61

    CAS  Google Scholar 

  241. Shanmugam MK, Rane G, Kanchi MM, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Tan BK, Kumar AP, Sethi G (2015) The multifaceted role of curcumin in cancer prevention and treatment. Molecules 20:2728–2769

    Google Scholar 

  242. Zhang J, Ahn KS, Kim C, Shanmugam MK, Siveen KS, Arfuso F, Samym RP, Deivasigamanim A, Lim LH, Wang L et al (2016) Nimbolide-induced oxidative stress abrogates STAT3 signaling cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model. Antioxid Redox Signal 24:575–589

    CAS  Google Scholar 

  243. Kim SM, Kim C, Bae H, Lee JH, Baek SH, Nam D, Chung WS, Shim BS, Lee SG, Kim SH et al (2015) 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways. Mol Carcinog 54:1132–1146

    CAS  Google Scholar 

  244. Kim C, Cho SK, Kim KD, Nam D, Chung WS, Jang HJ, Lee SG, Shim BS, Sethi G, Ahn KS (2014) Beta-Caryophyllene oxide potentiates TNFalpha-induced apoptosis and inhibits invasion through down-modulation of NF-kappaB-regulated gene products. Apoptosis 19:708–718

    CAS  Google Scholar 

  245. Young RC, Ozols RF, Myers CE (1981) The anthracycline antineoplastic drugs. N Engl J Med 305:139–153

    CAS  Google Scholar 

  246. Garg M, Kanojia D, Mayakonda A, Ganesan TS, Sadhanandhan B, Suresh S, Nagare RP, Said JW, Doan NB et al (2017) Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin. Sci Rep 7:9749

    Google Scholar 

  247. Cai YJ, Lu JJ, Zhu H, Xie H, Huang M, Lin LP, Zhang XW, Ding J (2008) Salvicine triggers DNA double-strand breaks and apoptosis by GSH-depletion-driven H2O2 generation and topoisomerase II inhibition. Free Radic Biol Med 45:627–635

    CAS  Google Scholar 

  248. Qing C, Jiang C, Zhang JS, Ding J (2001) Induction of apoptosis in human leukemia K-562 and gastric carcinoma SGC-7901 cells by salvicine, a novel anticancer compound. Anticancer Drugs 12:51–56

    CAS  Google Scholar 

  249. Mikula-Pietrasik J, Witucka A, Pakula M, Uruski P, Begier-Krasinska B, Niklas A, Tykarski A, Ksiazek K (2019) Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells. Cell Mol Life Sci 76:681–697

    CAS  Google Scholar 

  250. Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, Liang X (2018) The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res 37:266

    CAS  Google Scholar 

  251. Longley DB, Harkin DP, Johnston PG (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3:330–338

    CAS  Google Scholar 

  252. Wang L, Leite de Oliveira R, Huijberts S, Bosdriesz E, Pencheva N, Brunen D, Bosma A, Song JY, Zevenhoven J, Los-de Vries GT et al (2018) An acquired vulnerability of drug-resistant melanoma with therapeutic potential. Cell 173:1413–1425.e1414

    CAS  Google Scholar 

  253. Franzese E, Centonze S, Diana A, Carlino F, Guerrera LP, Di Napoli M, De Vita F, Pignata S, Ciardiello F, Orditura M (2019) PARP inhibitors in ovarian cancer. Cancer Treat Rev 73:1–9

    CAS  Google Scholar 

  254. Michels J, Vitale I, Galluzzi L, Adam J, Olaussen KA, Kepp O, Senovilla L, Talhaoui I, Guegan J, Enot DP et al (2013) Cisplatin resistance associated with PARP hyperactivation. Cancer Res 73:2271–2280

    CAS  Google Scholar 

  255. Rottenberg S, Jaspers JE, Kersbergen A, van der Burg E, Nygren AO, Zander SA, Derksen PW, de Bruin M, Zevenhoven J, Lau A et al (2008) High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc Natl Acad Sci U S A 105:17079–17084

    CAS  Google Scholar 

  256. Goodman M, Bostick RM, Kucuk O, Jones DP (2011) Clinical trials of antioxidants as cancer prevention agents: past, present, and future. Free Radic Biol Med 51:1068–1084

    CAS  Google Scholar 

Download references

Acknowledgements

This work was supported and funded by the Department of Biotechnology (DBT), Government of India under its Ramalingaswami Fellowship (No. BT/RLF/Re-entry/24/2014) award to Dr. Manoj Garg and Early Career Research Award (ECRA) from Science & Engineering Research Board (SERB; ECR/2016/001519), Department of Science and Technology, Government of India. We acknowledge BioRender online software for illustration of figures.

Author information

Authors and Affiliations

  1. Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Campus, Sector-125, Noida, Uttar Pradesh, 201313, India

    Anuradha Kirtonia & Manoj Garg

  2. Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Singapore

    Gautam Sethi

Authors
  1. Anuradha Kirtonia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gautam Sethi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Manoj Garg
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MG conceived the idea and designed the format of the manuscript. MG, AK, and GS wrote the manuscript and presented the concepts in the manuscript. MG and AK created the figures and the tables. MG, AK, and GS revised the manuscript and agreed to the published version of the manuscript.

Corresponding authors

Correspondence to Gautam Sethi or Manoj Garg.

Ethics declarations

Conflict of interest

All the authors have read the manuscript and have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kirtonia, A., Sethi, G. & Garg, M. The multifaceted role of reactive oxygen species in tumorigenesis. Cell. Mol. Life Sci. 77, 4459–4483 (2020). https://doi.org/10.1007/s00018-020-03536-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-020-03536-5

Keywords

Search

Navigation